1.6 Hz, 2H, oxazoline-CHaHbO), 4.12–4.08 (t, J = 8.4 Hz, 2H,
oxazoline-CHN), 3.63–3.60 (m, 4H, CH2CH2O), 2.13–2.11 (m,
4H, CCH2CH2), 1.58–1.54 (m, 4H, CH2CH2CH2), 1.39–1.35
(m, 4H, CH2CH2CH2), 0.89 (s, 18H, OSiC(CH3)3), 0.02 (s,12H,
OSiCH3). 13C NMR (100 MHz, CDCl3): d = 169.3, 142.5, 128.9,
127.7, 126.9, 75.3, 69.8, 63.1, 46.5, 33.3, 32.8, 26.2, 20.6, -5.0.
MS (ESI): m : z = 679.5 M+1+. Anal. calc. for C39H62N2O4Si2:
C, 68.98; H, 9.20; N, 4.13; found: C, 69.26; H, 8.58;
N, 4.61.
Synthesis of 1,1¢-{5,5-bis[(R)-4,5-dihydro-4-phenyloxazol-2-
yl]nonane-1,9} bis-(1,2-dimethyl-1H-imidazole) diOTs 10a
7a (0.270 g, 0.36 mmol) and 1,2-dimethyl-1H-imidazole were
dissolved in 2 mL of DMF, and the solution was heated to
70 ◦C for 24 h under N2 atmosphere. DMF was removed under
high vacuum. The residue was washed with Et2O (3 ¥ 10 mL)
until it cha◦nged to a light-yellow solid; yield: 0.290 g (85%).
1
mp: 82–84 C [a]20= +55.4 (c = 0.08, CH3OH), H NMR (400
MHz, CDCl3): d D= 7.71–7.66 (m, 6H, imidazole-CH + OTs-
ph-CH), 7.49–7.18 (m, 10H, OTs-ph-CH +oxazoline-ph-CH),
7.10–7.08 (m, 6H, OTs-ph-CH +oxazoline-ph-CH), 5.23–5.21
(dd, 2H, J = 8.0 Hz and 2.0 Hz, 2H, oxazoline-CHaHbO), 4.68–
4.64 (dd, 2H, J = 8.0 Hz and 2.0 Hz, 2H, oxazoline-CHaHbO),
4.17–4.07 (m, 4H, oxazoline-CHN + CH2CH2mim), 3.82 (s,
6H, imidazole-CH3), 3.48–3.45 (m, 4H, CCH2CH2), 2.65(s,
6H, imidazole-CH3), 2.31(s, 6H, OTs-CH3), 1.84–1.18(m, 8H,
CH2CH2CH2). 13C NMR (100 MHz, CDCl3): d = 168.6, 144.3,
144.1, 129.3, 128.9, 128.8, 127.8, 127.4, 126.9, 126.1, 122.9,
121.6, 76.9, 75.3, 69.6, 48.4, 35.5, 32.5, 29.8, 29.5, 21.5, 21.0.
MS (ESI): m : z = 304.4 M2+, m : z = 171.0 M-. HRMS (ESI):
calc. for C37H48N6O22+: 304.1919, found: 304.1914
Synthesis of 5,5-bis[(R)-4,5-dihydro-4-phenyloxazol-2-
yl]nonane-1,9-diol 6a
A solution of 5a (0.966 g, 1.40 mmol) in 32 mL of dry THF
was cooled to 0 ◦C under a N2 atmosphere. TBAF (2.100 g)
in 9 mL of THF was added to the solution dropwise, and the
resulting mixture was warmed to room temperature and stirred
for 8 h. The reaction mixture was subsequently quenched by
the addition of water (30 mL), washed with EtOAc (30 mL)
and then with brine (30 mL), and extracted with EtOAc (2 ¥
30 mL). The organic fractions were dried over Na2SO4, and the
solvent was removed under vacuum to afford the crude product,
which was purified by column chromatography (SiO2, EtOAc)
to afford 6a as a yellow oil; yield: 0.434 g (69%). [a]2D0 = +113.6
Synthesis of 1,1¢-{5,5-bis[(R)-4,5-dihydro-4-phenyloxazol-2-
yl]nonane-1,9} bis-(1,2-dimethyl-1H-imidazole) dihexafluoro-
phosphate 10e
1
(c = 0.50, CH2Cl2), H NMR (400 MHz, CDCl3): d = 7.31–
7.20 (m, 10H, oxazoline-ph-CH), 5.22–5.18 (dd, J = 8.0 Hz
and 2.0 Hz, 2H, oxazoline-CHaHbO), 4.65–4.61 (dd, J = 8.0
Hz and 2.0 Hz, 2H, oxazoline-CHaHbO), 4.12–4.08 (t, J = 8.0
Hz, 2H, oxazoline-CHN), 3.53–3.49 (m, 4H, CH2CH2O), 2.07–
2.00 (m, 4H, CCH2CH2), 1.41–1.38 (m, 4H, CH2CH2CH2),1.24–
1.22 (m, 4H, CH2CH2CH2). 13C NMR (100 MHz, CDCl3):
d = 169.4, 142.3, 128.9, 127.9, 126.9, 75.3, 69.5, 61.7, 46.7,
32.5, 20.5. MS (ESI): m : z = 451.3 M+1+. Anal. calc. for
C27H34N2O4: C, 71.97; H, 7.61; N, 6.22; found: C, 71.53; H, 7.08;
N, 5.79.
10a (0.290 g, 0.30 mmol) was dissolved in 2 mL of H2O, and
KPF6 (0.220 g, 1.10 mmol) was added to the solution and stirred
for 6 h at room temperature. The resultant white solid was filtered
and dried under vacuum to afford the product; yield: 0.250 g
(86%). mp: 108–111 ◦C [a]2D0 = +49.3 (c = 0.08, MeOH), 1HNMR
(400 MHz, DMSO): d = 7.64–7.58 (m, 4H, imidazole-CH), 7.57–
7.26 (m, 10H, oxazoline-ph-CH), 5.21–5.20 (dd, 2H, J = 8.0 Hz
and 2.0 Hz, 2H, oxazoline-CHaHbO), 4.67–4.66 (dd, 2H, J =
8.0 Hz and 2.0 Hz, 2H, oxazoline-CHaHbO), 4.11–4.07 (m, 6H,
oxazoline-CHN + CH2CH2mim), 3.74 (m, 6H, imidazole-CH3),
2.57(s, 6H, imidazole-CH3), 1.98–1.24(m, 12H, CH2CH2CH2).
13C NMR (100 MHz, CDCl3): d = 169.4, 142.3, 139.3, 128.9,
128.6, 127.8, 127.4, 126.9, 126.1, 122.8, 121.6, 69.6, 48.4, 35.5,
32.5, 29.8, 29.5, 21.0, 10.2. MS (ESI): m:z = 304.6 M2+, m:z
= 144.9 M-. HRMS (ESI): calc. for C37H48N6O22+: 304.1919,
Synthesis of 5,5-bis[(R)-4,5-dihydro-4-phenyloxazol-2-
yl]nonane-1,9-ditosylate 7a
To a solution of 6a (0.434 g, 0.96 mmol) in 20 mL of DCM, TsCl
(0.736 g, 3.86 mmol) and Et3N (0.390 g, 3.86 mmol) were added
under a N2 atmosphere, and the mixture was stirred for 8 h. The
reaction mixture was subsequently quenched by the addition of
brine (20 mL). The organic layer was washed with water (3 ¥
20 mL) and dried over Na2SO4, and the solvent was removed
under vacuum to afford the crude product, which was purified by
column chromatography (SiO2, EtOAc/PE60-90 1/1) to afford
7a; yield: 0.540 g (70%). mp: 116–118 ◦C [a]D20 = +162.5 (c = 2.00,
-
found: 304.1914, calc. for PF6 : 144.9807, found: 144.9809.
Acknowledgements
The National Technological Project of the Manufacture and
Innovation of Key New Drugs (2009ZX09103-143) and the
Major Projects Cultivating Special Program in Technology
Innovation Program (Grant NO. 2011CX01008) of the Beijing
Institute of Technology are gratefully acknowledged for their
financial support.
1
CH2Cl2), H NMR (CDCl3): d = 7.76 (m, 4H, OTs-ph-CH),
7.35–7.23 (m, 10H, OTs-ph-CH + oxazoline-ph-CH), 5.23–5.19
(dd, J = 8.0 Hz and 2.0 Hz, 2H, oxazoline-CHaHbO), 4.66 (dd,
J = 8.0 Hz and 2.0 Hz, 2H, oxazoline-CHaHbO), 4.11 (t, J = 8.0
Hz, 2H, oxazoline-CHN), 4.02 (t, J = 8.0 Hz, 4H, CH2CH2O),
2.42 (s, 6H, OTs-CH3), 2.04–1.95 (m, 4H, CCH2CH2), 1.70–
1.65 (m, 4H, CH2CH2CH2), 1.33–1.36 (m, 4H, CH2CH2CH2).
13C NMR (100 MHz, CDCl3): d = 168.4, 144.8, 142.2, 129.9,
128.9, 127.9, 126.8, 75.2, 70.3, 69.7, 46.1, 32.3, 29.1, 21.7, 20.1.
MS (ESI): m : z = 759.4 M+1+, Anal. calc. for C41H42N2O8S2:
C, 64.88; H, 6.11; N, 3.69; found: C, 64.54; H, 6.53;
N, 3.48.
References
1 D. A. Evans, K. A. Woerpel, M. M. Hinman and M. M. Faul, J. Am.
Chem. Soc., 1991, 113, 726–728.
2 R. Rasappan, D. Laventine and O. Reiser, Coord. Chem. Rev., 2008,
252, 702–714.
3 E. J. Corey, N. Imai and H. Y. Zhang, J. Am. Chem. Soc., 1991, 113,
728–729.
2970 | Green Chem., 2011, 13, 2963–2971
This journal is
The Royal Society of Chemistry 2011
©